| Literature DB >> 17275337 |
Gary Price1, Mara Cercignani, Geoffrey J M Parker, Daniel R Altmann, Thomas R E Barnes, Gareth J Barker, Eileen M Joyce, Maria A Ron.
Abstract
A model of disconnectivity involving abnormalities in the cortex and connecting white matter pathways may explain the clinical manifestations of schizophrenia. Recently, diffusion imaging tractography has made it possible to study white matter pathways in detail and we present here a study of patients with first-episode psychosis using this technique. We selected the corpus callosum for this study because there is evidence that it is abnormal in schizophrenia. In addition, the topographical organization of its fibers makes it possible to relate focal abnormalities to specific cortical regions. Eighteen patients with first-episode psychosis and 21 healthy subjects took part in the study. A probabilistic tractography algorithm (PICo) was used to study fractional anisotropy (FA). Seed regions were placed in the genu and splenium to track fiber tracts traversing these regions, and a multi-threshold approach to study the probability of connection was used. Multiple linear regressions were used to explore group differences. FA, a measure of tract coherence, was reduced in tracts crossing the genu, and to a lesser degree the splenium, in patients compared with controls. FA was also lower in the genu in females across both groups, but there was no gender-by-group interaction. The FA reduction in patients may be due to aberrant myelination or axonal abnormalities, but the similar tract volumes in the two groups suggest that severe axonal loss is unlikely at this stage of the illness.Entities:
Mesh:
Year: 2006 PMID: 17275337 PMCID: PMC2387200 DOI: 10.1016/j.neuroimage.2006.12.019
Source DB: PubMed Journal: Neuroimage ISSN: 1053-8119 Impact factor: 6.556
Summary of patient and control characteristics
| FE psychosis patients | Controls | |
|---|---|---|
| Age | 23.6 years | 29.4 years |
| Age range | 17–38 years | 16–42 years |
| Gender | 8 male | 6 male |
| 10 female | 15 female | |
| Handedness | 16 Right | 15 right |
| 2 Left | 6 left | |
| Diagnosis | 13 schizophrenia | – |
| 5 schizoaffective | ||
| Antipsychotic medication (18 FE patients) | 2 amisulpride | None |
| 1 flupentixol | ||
| 12 olanzapine | ||
| 3 risperidone | ||
| Antipsychotic medication | – | |
| Duration mean | 61 days | |
| Duration range | 8–153 days | |
| Duration up to 1 month | 7 patients | |
| Duration 1–2 months | 6 patients | |
| Duration 2–3 months | 1 patient | |
| Duration 3–4 months | 3 patients | |
| Duration 4–5 months | 0 patient | |
| Duration over 5 months | 1 patient | |
| Other medications (2 FE patients) | 1 lithium | None |
| 1 lithium and sodium valproate |
FE = first-episode.
Fig. 3(A) The estimated genu tract volumes compared in the patient and control population at each of the probabilistic thresholds (0.001, 0.002, 0.006, 0.013, 0.03). (B) The estimated splenium tract volumes compared in the patient and control population at each of the probabilistic thresholds (0.001, 0.002, 0.006, 0.013, 0.03). (C) Comparisons of the estimated genu tract FA between patients and controls at each of the probabilistic thresholds (0.001, 0.002, 0.006, 0.013, 0.03). (D) Comparisons of the estimated splenium tract FA between patients and controls at each of the probabilistic thresholds (0.001, 0.002, 0.006, 0.013, 0.03).
Multiple linear regression analysis, exploring the differences in FA between patients and controls, in the genu and splenium at different probability thresholds
| FA differences | Group coefficient | Significance ( | 95% confidence interval |
|---|---|---|---|
| Threshold 0.001 | − 0.013 | 0.163 | − 0.031 to 0.005 |
| Threshold 0.002 | − 0.013 | 0.144 | − 0.031 to 0.005 |
| Threshold 0.006 | − 0.021 | 0.021* | − 0.039 to − 0.003 |
| Threshold 0.013 | − 0.022 | 0.022* | − 0.041 to − 0.003 |
| Threshold 0.03 | − 0.016 | 0.168 | − 0.038 to 0.007 |
| Threshold 0.001 | − 0.026 | 0.246 | − 0.069 to 0.018 |
| Threshold 0.002 | − 0.030 | 0.192 | − 0.075 to 0.015 |
| Threshold 0.006 | − 0.036 | 0.122 | − 0.081 to 0.010 |
| Threshold 0.013 | − 0.040 | 0.078 | − 0.085 to 0.005 |
| Threshold 0.03 | − 0.039 | 0.062 | − 0.080 to 0.002 |
Age, gender and tract volume entered as covariates.
Group coefficient = mean FA in patients − mean FA in controls, after adjusting for age, gender and tract volume. *P < 0.05.